Viemed Healthcare (VMD) Income from Continuing Operations (2018 - 2026)
Viemed Healthcare (VMD) reported Income from Continuing Operations of 2713000.0 for Q1 2026, little changed on a YoY basis from 2710000.0 in Q1 2025, and down 53.35% quarter-over-quarter from 5816000.0 in Q4 2025.
Viemed Healthcare (VMD) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Viemed Healthcare has reported Income from Continuing Operations for 9 years, with the latest figure at 2713000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations changed 0.11% year-over-year to 2713000.0; the trailing twelve-month figure through Mar 2026 stood at 15379000.0 (up 22.87% YoY), and the FY2025 full-year result was 15376000.0, up 34.77% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 2713000.0, down from 5816000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 5816000.0 in Q4 2025, with the low at 967000.0 in Q2 2022.
- Historically, Income from Continuing Operations has averaged 2703705.88 across 5 years, with a median of 2710000.0 in 2025.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations sank 41.03% — and 2023, when it surged 176.68%.
- Viemed Healthcare's Income from Continuing Operations stood at 2438000.0 in 2022, then soared by 42.62% to 3477000.0 in 2023, then gained by 27.24% to 4424000.0 in 2024, then soared by 31.46% to 5816000.0 in 2025, then slumped by 53.35% to 2713000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 2713000.0 (Q1 2026), 5816000.0 (Q4 2025), and 3600000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Viemed Healthcare | 410.03 Mn | 402.20 Mn | 42.83 Mn | 2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.71 Mn |
| Dec 31, 2025 | 5.82 Mn |
| Sep 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 3.25 Mn |
| Mar 31, 2025 | 2.71 Mn |
| Dec 31, 2024 | 4.42 Mn |
| Sep 30, 2024 | 3.91 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 3.48 Mn |
| Sep 30, 2023 | 2.92 Mn |
| Jun 30, 2023 | 2.33 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 2.44 Mn |
| Sep 30, 2022 | 1.06 Mn |
| Jun 30, 2022 | 967,000.00 |
| Mar 31, 2022 | 1.76 Mn |
| Dec 31, 2021 | 4.09 Mn |
| Sep 30, 2021 | 1.79 Mn |
| Jun 30, 2021 | 1.57 Mn |